{"transactions":[{"id":737503,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-06-15T21:23:56.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":169500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. 23,542 shares vest upon grant and 4,708 shares vest over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. 23,542 shares vest upon grant and 4,708 shares vest over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":169500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":169500},"source":{"system":"sec-edgar","filing":"0001213900-26-068917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000121390026068917/ownership.xml","form_type":"4/A","original_submission_date":"2026-05-20"}},{"id":769666,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-05-20T20:30:22.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":169500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":169500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":169500},"source":{"system":"sec-edgar","filing":"0001213900-26-059559","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000121390026059559/ownership.xml","form_type":"4"}},{"id":1078969,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2025-07-30T20:30:09.000Z","date":"2025-07-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"2,500 of the stock options vest on July 28, 2026 and 1/36th of the remaining options vest at the end of each successive month thereafter."}],"balance_after":101557,"derivative":{"exercise_price":4.71,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-25-069302","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000121390025069302/ownership.xml","form_type":"4"}},{"id":1433401,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2024-08-14T20:15:20.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":40256,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"10,064 of the stock options vest on August 12, 2025 and 1/36th of the remaining options vest at the end of each successive month thereafter."}],"balance_after":915565,"derivative":{"exercise_price":0.34,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":40256},"source":{"system":"sec-edgar","filing":"0001213900-24-069038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000121390024069038/ownership.xml","form_type":"4"}},{"id":1539762,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2024-04-17T20:33:14.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":228119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"57,030 of the stock options vest on the first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter."}],"balance_after":875309,"derivative":{"exercise_price":1.14,"expiration_date":"2034-04-15","underlying":"Common Stock","underlying_shares":228119},"source":{"system":"sec-edgar","filing":"0001213900-24-033833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000121390024033833/ownership.xml","form_type":"4"}},{"id":1792833,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2023-08-30T20:46:27.000Z","date":"2023-08-28","kind":"grant","planned":false,"acquired":true,"shares":570329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"142,582 of the stock options vest on March 6, 2024 and 1/36th of the remaining options vest at the end of each successive month thereafter."}],"balance_after":647190,"derivative":{"exercise_price":0.75,"expiration_date":"2033-08-28","underlying":"Common Stock","underlying_shares":570329},"source":{"system":"sec-edgar","filing":"0001213900-23-072249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000121390023072249/ownership.xml","form_type":"4"}},{"id":2104933,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2022-11-23T13:00:21.000Z","date":"2022-11-21","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter."}],"balance_after":76861,"derivative":{"exercise_price":0.75,"expiration_date":"2032-11-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-22-074723","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000121390022074723/ownership.xml","form_type":"4"}},{"id":2624718,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-07-26T20:15:21.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":18605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest equally over a period of three years from the date of grant."}],"balance_after":41861,"derivative":{"exercise_price":5,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":18605},"source":{"system":"sec-edgar","filing":"0001213900-21-038634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000121390021038634/ownership.xml","form_type":"4"}},{"id":4221359,"issuer":{"id":87936,"kind":"organization","name":"Guardion Health Sciences, Inc.","symbol":"GHSI"},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Accounting Officer","other_text":"Controller"}}],"security":"Common Stock","published_at":"2017-08-30T23:33:21.000Z","date":"2017-08-30","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The Board of Directors authorized the grant on August 10, 2017.  The stock certificate representing the shares was delivered to Reporting Person on August 30, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are fully vested upon issuance."}],"balance_after":105000,"source":{"system":"sec-edgar","filing":"0001511906-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000151190617000003/primary_doc.xml","form_type":"4"}},{"id":4448009,"issuer":{"id":87936,"kind":"organization","name":"Guardion Health Sciences, Inc.","symbol":"GHSI"},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Controller"}}],"security":"Common Stock","published_at":"2017-02-14T20:45:09.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors removed the vesting requirement such that the shares vest immediately upon issuance."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001511906-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000151190617000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2017-01-03"}},{"id":4507266,"issuer":{"id":87936,"kind":"organization","name":"Guardion Health Sciences, Inc.","symbol":"GHSI"},"owners":[{"id":38064,"kind":"person","name":"Townsend John","position":1,"cik":"0001511906","reported_name":"Townsend John","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Controller"}}],"security":"Common Stock","published_at":"2017-01-03T21:36:10.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock for services vesting 50% on June 30, 2017 and 50% on December 31, 2017."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001135337-17-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511906/000113533717000005/primary_doc.xml","form_type":"4"}}]}